MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort.

MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort.

Item
http://www.wikidata.org/entity/Q35137663
Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic reviewVascular Smooth Muscle as a Target for Novel Therapeutics.Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical PerspectiveMicroRNAs, heart failure, and aging: potential interactions with skeletal muscle.MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes.Molecular Interplay between microRNA-34a and Sirtuin1 in Hyperglycemia-Mediated Impaired Angiogenesis in Endothelial Cells: Effects of Metformin.Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.Circulating microRNAs: a novel potential biomarker for diagnosing acute aortic dissection.Systems genetics identifies a co-regulated module of liver microRNAs associated with plasma LDL cholesterol in murine diet-induced dyslipidemia.Association between hypertension and circulating vascular-related microRNAs.MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor.
P2860

MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort.

Item
http://www.wikidata.org/entity/Q35137663
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@ast
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@en
type
label
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@ast
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@en
prefLabel
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@ast
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
MiR-34a, miR-21 and miR-23a as ...... mation in a 32 patient cohort.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932